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Background: Recent trials in Bangladesh, Nepal, and Pakistan have shown that chlorhexidine is an effective
antiseptic for umbilical cord care compared to existing community-based cord care practices. Because of the
aggregate reduction in neonatal mortality in these trials, interest is high in introducing a 7.1% chlorhexidine
digluconate liquid or gel that delivers 4% chlorhexidine for umbilical cord care in Bangladesh and elsewhere.
Methods: In 2010, we conducted a household survey applying a contingent valuation method with 1717 eligible
couples (pregnant women or women with a first child younger than 6 months old, and their husbands) in the rural
subdistricts of Abhoynagar and Mirsarai in Bangladesh to assess their willingness to pay for three types of umbilical
cord care products at different price points. Each respondent was asked about willingness to pay prefixed prices for
any one of three 7.1% chlorhexidine digluconate products: 1) a single-dose liquid, 2) a multi-dose liquid, or 3) a gel
formulation. Each also reported the maximum price they were independently willing to pay for their selected
product. We compared participant willingness-to-pay responses to the prefixed prices with their independently
reported maximum prices for each type of the product separately. The comparison identified to what extent the
respondents’ positive responses to the prefixed prices matched their independently reported maximum prices.
Results: This cross matching revealed that willingness to pay the prefixed prices was 41% for the single-dose liquid,
33% for the multi-dose liquid, and 31% for the gel formulation. Although the majority of the respondents were
unwilling to pay the prefixed prices, all were willing to pay some amount and reported they could borrow money
if necessary. Subsequent analysis of responses to the multi-dose liquid showed borrowing money would not be
required if the unit price was Bangladeshi taka 15–25.
Conclusions: A unit price of Bangladeshi taka 15–25 (US$0.21–0.35) for multi-dose 7.1% chlorhexidine digluconate
liquid would be affordable to the primary target population in Bangladesh. Although a large market demand could
be generated if the product were available at this price point, subsidization may be required to achieve optimal
coverage, especially among poorer families.
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The deadline for the Millennium Development Goals
(MDG) is rapidly approaching, yet the 2010 Millennium
Development Goals Report revealed that without a major
push, many of the MDG targets including MDG 4 on re-
ducing child mortality are likely to be missed in most re-
gions [1]. A major obstacle to the progress of MDG 4 has
been the inability to save the lives of neonates in many
low- and middle-income countries. Reaching MDG 4 will
require universal coverage with key effective, affordable
interventions for newborns such as chlorhexidine for um-
bilical cord care. Recently, chlorhexidine for umbilical
cord care has been highlighted as an “affordable, effective,
but underutilized life-saving commodity” for newborn
health by the UN Commission on Life-Saving Commod-
ities for Women and Children [2].
The 1998 World Health Organization guidelines on
cord care recommend dry cord care as well as the appli-
cation of topical antiseptics to the cord stump in areas
with high infection risk [3,4]. The recently cut umbilical
cord is an entry point for bacteria that cause newborn
sepsis and death. Ensuring optimal cord care at birth and
in the first week of life, especially in settings with poor hy-
giene, is a crucial strategy to prevent life-threatening sep-
sis and cord infections, and avert preventable neonatal
deaths. In rural Bangladesh, 80% of childbirth takes place
at home under poor hygienic conditions [5]. Of these,
about 60% are attended by untrained attendants; 12% by
trained traditional birth attendants; and 4% by relatives,
neighbors, and friends. In these settings, applying sub-
stances such as mustard oil, Nebanol powder (neomycin
sulphate + bacitracin zinc preparation), spirit (ethyl alco-
hol), homeopathic medicines and belay sindoor (vermilion
powder) are common.
Recent trials in Bangladesh [6], Nepal [7], and Pakistan
[8] have shown that chlorhexidine is an effective antisep-
tic when used for umbilical cord care. Data from the
three countries indicate that use of chlorhexidine for
umbilical cord care results in an aggregate 23% reduc-
tion in neonatal mortality [9].
In Bangladesh, the majority of neonatal death are due to
severe infection which includes sepsis, meningitis, pneu-
monia, and tetanus (20%), intrapartum-related or asphyxia
(23%) and complications of preterm birth (45%) [10]. In
2010, an estimated 102000 neonatal deaths occurred
Bangladesh [10].
Therefore, interest in introducing a 7.1% chlorhexi-
dine digluconate liquid or gel that delivers 4% chlor-
hexidine for umbilical cord care is high. Assessing
the willingness to pay (WTP) of potential users for a
chlorhexidine umbilical cord care product could in-
form the most appropriate price point that supports
sustainable supply and demand and facilitate optimal
uptake such that the product would be applied to allinfants born in Bangladesh within the first 24 hours
of birth.Methods
In 2010, we conducted a household survey applying a
contingent valuation method (CVM) with 1717 eligible
couples in Abhoynagar and Mirsarai subdistricts in
Bangladesh. Our objective was to assess their willingness
to pay for three types of 7.1% chlorhexidine digluconate
(which delivers 4% chlorhexidine) umbilical cord care
products at different price points. The three products
were 1) a single-dose liquid, 2) a multi-dose liquid, and
3) a gel preparation of 7.1% chlorhexidine digluconate.
We conducted the household survey April 2010 through
July 2010. Using a structured questionnaire (Additional
file 1), we interviewed eligible couples—pregnant women
or women with a first-born child younger than 6 months
old, and their husbands—living in the rural subdistricts of
Abhoynagar and Mirsarai. Our total estimated sample size
of 1700 was based on the assumption that there would be
a 10% difference in the proportion of the willingness to
pay for chlorhexidine products between eligible couples in
the two sites, Abhoynagar and Mirsarai. We used a stand-
ard formula where n = sample size, p1 = .5 (proportion of
willingness to pay in pregnant women and women with
first-born child aged <6 months), p2 = .4 (proportion of
willingness to pay in husbands), difference = p1-p2 = .1
with power 80% and 95% confidence level. Considering
10% attrition, a total of 425 respondents in each group
(two categories of women and their husbands) were calcu-
lated for Abhoynagar and Mirsarai.
The required number of respondents for each category
was randomly selected from International Centre for
Diarrhoeal Disease Research, Bangladesh (icddr,b) data-
bases, which are populated by ongoing surveillance in
these two areas. Wives and husbands were interviewed
separately.
Using the CVM, as explained in the following steps to
assess willingness to pay [11,12], the interviewer first
presented a hypothetical scenario to the respondent that
included a clear description of three different products
containing 7.1% chlorhexidine digluconate: single- and
multi-dose liquid, and multi-dose gel. We then explained
each of the product indications, benefits, advantages
over alternatives, and side effects. We asked about their
interest in any one type of the product, and preference
for type of product (i.e., liquid or gel) and dosage
regimen (i.e., single day dose or multi-day dose). If they
responded positively, we reminded the respondents to
take into account other products currently available and
their household budget. We informed them that there
was no right or wrong answer and that they could de-
cide to reject the product at any price.
Coffey et al. BMC International Health and Human Rights 2013, 13:44 Page 3 of 9
http://www.biomedcentral.com/1472-698X/13/44Based on the respondent’s product preference, we then
initiated a bidding game by introducing the four differ-
ent prefixed prices for each of the three products. The
prefixed price bids for the single-dose chlorhexidine li-
quid were Tk. 27, 32, 35, and 30 (the international ex-
change rate in December 2010 was US$1 = Bangladeshi
Tk. 70). For the multi-dose liquid and the gel prepar-
ation they were Tk. 45, 55, 60, and 50. Starter price bids
for the liquid products—Tk. 27 for the single-dose
liquid and Tk. 45 for the multi-dose liquid—were sug-
gested by a Bangladeshi manufacturer that had pro-
duced a 7.1% chlorhexidine digluconate product for an
operations research. The cost of the gel, Tk. 45, was in-
ferred from other gel products in the marketplace (none
of which are used for umbilical cord care). The subse-
quent increases in proposed prices for all three products
(moderate, higher, lower) were determined by consider-
ing the market price of locally available alternative
allopathic products for umbilical cord care such as neo-
mycin sulphate + bacitracin zinc powder and ointment,
chlorhexidine digluconate 0.5% w/w in 70% isopropanol
solution, povidone iodine lotion, oral amoxicillin drops,
cepharadine drops, and erythromycin drops. All of these
drug products could be used for a variety of medical
treatments; they are not specifically used for umbilical
cord care. The price of the allopathic products being
currently used for neonatal cord care ranged between
Tk. 10 to Tk. 60, with the popular ones costing between
Tk. 25 and Tk. 35 in the study areas.
To analyze the data collected, we cross-matched the
respondents’ positive responses to the prefixed prices with
their independently reported maximum price for all three
products. Thus, the proportion of respondents’ willing-to-
pay prices that were either less, equivalent, or more than
the prefixed price(s) was identified by type of preparation
they preferred. Finally, based on the respondents’ pro-
posed coping mechanism to pay a higher price than theirFigure 1 Sequence of questions for bidding game and independent w
questions in Foreit and Foreit [12].maximum willingness to pay, we identified a price range
that was affordable for all respondents.
We first asked whether respondents could pay the
lowest prefixed price for the product chosen and then
asked about the moderate increase in price for the same.
Based on respondents’ “yes” or “no” responses to the
moderate increase in price, we then asked their willing-
ness to pay either a higher or lower price. Finally, we
asked an open-ended question on what would be the
maximum price they would be independently willing to
pay (i.e., regardless of prefixed prices assigned to each
product) and how they would cope if the price was
higher than their ability to afford it (Figure 1).
The Ethical Review Committee at icddr,b approved
this protocol (number PR-09077). Informed written con-
sent was obtained from each of the respondents at the
beginning the interview using the approved voluntary
consent form.
After editing, all quantitative data were entered into
visual Fox Pro version 6.0 (Microsoft Corporation,
Washington, USA) and cleaned. Univariate and bivariate
analyses were done using SPSS Statistics version 13
(IBM Corporation, New York, USA) and results were
presented by frequency distribution, cross tabulation,
mean, and median.
Results
We interviewed a total of 1717 respondents: 427 preg-
nant women, 445 women with a first-born child less
than 6 months old, and 845 husbands (see Table 1 for
demographic characteristics of respondents).
The proportion of respondents earning more than Tk.
5000 per month was higher in Mirsarai (77%) compared
to Abhoynagar (58%). The average monthly income de-
rived from their primary source was higher in Mirsarai
(Tk. 12300 equivalent to US$176) than Abhoynagar (Tk.
7315 equivalent to US$105) and statistically significantillingness to pay. *Adapted from sequence of willingness to pay
Table 1 Demographic characteristics of respondents (n = 1717)
Variables Abhoynagar % Mirsarai %
n = 854 n = 863
Age in years Wife n = 433 Husband n = 421 Total n = 854 Wife n = 439 Husband n = 424 Total n = 863
<20 23.1 0.0 11.8 13.8 0.2 7.2
20–24 38.2 14.6 26.7 39.1 7.4 23.7
25–29 23.3 34.7 28.9 30.5 22.7 26.7
30–34 10.8 20.3 15.4 12.0 28.7 20.1
35–39 4.1 15.6 9.7 3.8 19.9 11.6
40+ 0.5 14.8 7.5 0.9 21.1 10.7
Median age in years 22 30 26 24 32 28
Education/schooling
No school; can’t sign 1.4 4.3 2.8 4.1 9.3 6.6
No school; can sign 8.5 11.0 9.7 13.1 21.5 17.2
Primary school incomplete (1–5 years) 12.6 22.5 17.4 11.7 20.8 16.1
Primary school complete 11.7 9.1 10.4 8.1 6.0 7.1
Secondary school incomplete (6–10 years) 55.6 37.1 46.5 53.5 28.9 41.6
Secondary school complete 5.5 6.0 5.7 4.5 7.2 5.8
High school incomplete 0.9 2.4 1.6 2.9 0.7 1.9
High school complete 2.7 5.3 4.0 2.0 2.6 2.3
Degree/graduation complete 0.2 1.4 0.8 0.0 1.9 0.9
Other 0.9 0.9 0.9 0.0 1.0 0.5
Occupation
Housewife 98.4 0.0 50.3 99.3 0.0 51.1
Farmer/agriculture 0.5 20.3 10.2 0.0 16.7 8.1
Small trade 0.0 24.6 12.0 0.0 31.6 15.3
Day laborer 0.2 15.1 7.5 0.7 10.5 5.5
Rickshaw/van puller 0.0 6.7 3.3 0.0 6.0 2.9
Hawker 0.0 0.2 0.1 0.0 1.0 0.5
Driver 0.0 2.2 1.1 0.0 5.7 2.8
Petty job 0.5 22.7 11.3 0.0 19.9 9.6
Unemployed 0.0 3.7 1.9 0.0 5.5 2.7
Other 0.5 4.3 2.3 0.0 3.1 1.5
Number of children Abhoynagar % Mirsarai %
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2010 was US$1 = Bangladeshi Tk. 70]. However, this dif-
ference in income did not appear to affect their willing-
ness to pay; we did not find any correlation between
income and willingness to pay (r = 0.085).The large majority of the women (>91%) in both sites
reported that they had used some type of product for
drying and preventing cord infection when their last
child was born. Husbands were less aware of the subject
than their wives—of the husbands, 6% to 9% had no
Table 2 Respondents’ WTP for chlorhexidine gel*
Price category Price in taka Abhoynagar % Mirsarai % Overall %
n = 605 n = 504 n = 1109
PW n = 163 MB n = 148 HS n = 294 PW n = 108 MB n = 132 HS n = 264
Less than prefixed prices <=15 5 12 6 2 3.8 3 5 69
16–25 33 36 31 11 29.5 29 29
26–35 20 17 19 24 25.8 30 23
36–44 15 10 10 18 11.4 12 12
Equivalent to prefixed prices 45–60 24 24 31 37 19.7 22 26 31
More than prefixed prices 61+ 4 2 3 8 9.8 5 5
*Percentages may not equal 100 due to rounding.
PW = pregnant woman; MB =mother with baby less than 6 months old; HS = husband.
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did not know about use of any such product.
Respondents reported that they had used various
products for umbilical cord care. Use of mustard oil
ranked at the top followed by Nebanol powder (neomy-
cin sulphate + bacitracin zinc preparation), spirit (ethyl
alcohol), homeopath medicines and belay sindoor (ver-
milion powder). Very few had used more traditional
products such as cow dung, ash dust, chili, turmeric
paste, or breast milk.
All respondents were interested in using 7.1% chlor-
hexidine digluconate and participated in the willingness-
to-pay bidding game. However, their responses differed
in relation to the dosage and preparation options. Al-
though 65% (n = 1109) of the respondents preferred the
gel preparation, their overall willingness to pay the
prefixed prices for it was lowest (31%). The remaining
35% of the respondents (n = 608) preferred liquid prepa-
rations. The majority of respondents who preferred one
of the three products were willing to pay less than the
prefixed prices, but all respondents were willing to pay









<=15 16 25 26 35 36 44 45
Figure 2 Graph representation of respondents’ WTP for chlorhexidineGel product
For the gel product, 31% of our respondents were willing
to pay the equivalent of or more than the prefixed prices
with 26% willing to pay prices that were equivalent to
prefixed prices of Tk. 45 to Tk. 60 and 5% willing to pay
more than the prefixed prices of more than Tk. 61. The
remaining 69% of our respondents were willing to pay
between Tk. 15 and Tk. 44 (Table 2 and Figure 2).
Single-dose liquid preparation
For the single-dose liquid preparation, 41% of our re-
spondents were willing to pay the equivalent of or more
than the prefixed prices; 39% were willing to pay prices
that were equivalent to the prefixed prices of Tk. 27 to
Tk. 35, and 2% were willing to pay more than the
prefixed prices of Tk. 36 to Tk. 50. The remaining 59%
of our respondents were willing to pay between Tk. 15
and Tk. 26 (Table 3 and Figure 3).
Multi-dose liquid preparation
For the multi-dose liquid preparation, 33% of our re-










Table 3 Respondents’ WTP for a single-dose chlorhexidine liquid*
Price category Price in taka Abhoynagar % Mirsarai % Overall %
n = 163 n = 196 n = 359
PW n = 32 MB n = 62 HS n = 69 PW n = 63 MB n = 55 HS n = 78
Less than prefixed prices <=15 33 16 22 15 7 17 17 59
16–26 30 50 44 42 46 38 42
Equivalent to prefixed prices 27–35 37 34 33 44 41 43 39 41
More than prefixed prices 36–50 0 0 1 0 6 3 2
*Percentages may not equal 100 due to rounding.
PW = pregnant woman; MB =mother with baby less than 6 months old; HS = husband.
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that were equivalent to prefixed prices between Tk. 45
and Tk. 60, and 3% willing to pay more than the prefixed
prices of more than Tk. 61. The remaining 67% of our
respondents were willing to pay between Tk. 15 and Tk.
44 (Table 4 and Figure 4).
In cases where the prefixed prices were higher than
the maximum willingness to pay, the majority of our
respondents reported that they would cope with the
shortfall by borrowing money. However, for prices ran-
ging from Tk. 15 to Tk. 25, respondents did not report
such coping mechanism. Overall, 33% of the respon-
dents were willing to pay Tk. 15 to Tk. 25 for the multi-
dose chlorhexidine liquid, and the remaining 67% were
willing to pay some amount from Tk. 25 to more than
Tk. 60. It is expected that all respondents in this 67%
would be willing to pay lesser prices ranging between
Tk. 15 and Tk. 25 because originally they were willing to
pay more.
Following cross matching, only 31% of the respondents
were willing to pay the prefixed prices ranging between
Tk. 45 and Tk. 60 for the gel product, 41% of the re-
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Figure 3 Graph representation of respondents’ WTP for single-dose cbetween Tk. 27 and Tk. 35 for the single-dose liquid
preparation, and only 33% of the respondents were will-
ing to pay the prefixed prices of between Tk. 45 and Tk.
60 for the multi-dose liquid preparation. We further
assessed the price implications of the multi-dose liquid
preparation because it was the product used in the
Bangladesh randomized controlled trial [6]. If the unit
price was set at any point between Tk. 45 and Tk. 60 for
this product, 67% of the respondents would need to bor-
row money in order to purchase it (Table 5).
Discussion
Given the pattern of willingness-to-pay responses and the
proposed coping mechanisms to higher prices, this study
found that the unit price of a 7.1% chlorhexidine
digluconate product (delivering 4% chlorhexidine) should
range between Tk. 15 and Tk. 25 for it to be accessible.
The majority of the respondents were not willing to
pay the prefixed prices, but everyone was willing to pay
some amount of money. This could be because the
prefixed prices we used were too high. However, for the
sake of preventing newborn cord infections, the majority










Table 4 Respondents’ WTP for multi-dose chlorhexidine liquid
Price category Price in taka Abhoynagar % Mirsarai Overall %
n = 86 n = 163 n = 249
PW n = 19 MB n = 9 HS n = 58 PW n = 42 MB n = 39 HS n = 82
Less than prefixed prices <=15 5 22 7 0 3 4 4 67
16–25 26 33 29 26 39 24 29
26–35 21 22 17 26 23 26 23
36–44 26 0 28 19 23 20 11
Equivalent to prefixed prices 45–60 16 22 12 19 8 21 30 33
More than prefixed prices 61+ 5 0 7 10 5 6 3
PW = pregnant woman; MB =mother with baby less than 6 months old; HS = husband.
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product that would prevent infection in their newborn
was very similar across all respondent groups. Although
income level has been positively associated with the like-
lihood of a doctor’s visit for a sick child [13], our find-
ings suggest that behavior related to preventive medicine
may be different. Interestingly, we did find one gender
differential in willingness to pay where husbands reported
being willing to pay more in Mirsarai compared to
Abhoynagar for multi-dose liquid product.
The most popular product that we introduced into this
willingness-to-pay study was the gel. Although this par-
ticular product was not used in any of the randomized
controlled trials performed in Nepal, Bangladesh, and
Pakistan, it is currently being scaled up for general use
in Nepal. Results from a hospital-based randomized
non-inferiority trial of chlorhexidine gel and liquid sug-
gest that satisfaction and compliance were high for both
products and that the gel formulation was not inferior to
the liquid [14]. For this reason, we chose to include gel
in the current study as the gel could be an option for
Bangladesh in the future, subject to increasing produc-








<=15 16 25 26 35 36 44 45
Figure 4 Graph representation of respondents’ WTP multi-dose chlorfor chlorhexidine gel demonstrated by a large majority
of the study participants is indicative of impending de-
mand for the gel product.
The greatest challenge to the contingent valuation
method is whether responses to hypothetical questions
were representative of respondents’ actual payment
behavior when faced with reality (hypothetical versus ac-
tual payment), or how well did hypothetical WTP
predict what people were actually willing to pay. For
assessing validity of such hypothetical WTP responses, a
simulated market experiment [15] is necessary where
hypothetical WTP is compared with actual purchase
decision. However, we could not do such experiment for
the product of interest was not commercially available in
the local market at the time this survey. Further study
limitations may reflect starting point bias in the bid-
ding game used. While we tried to reflect accurate
pricing as much as possible, it is likely that actual
pricing will be different when the product is eventu-
ally released on the market in Bangladesh. This
starting point bias may be especially important if the











Table 5 Price implications of a multi-dose chlorhexidine liquid
Price in taka* Percent willing to pay Demand side implications
15–25 (US$0.21–0.35) 33 Borrowing money is not required by any respondent interviewed.
26–35 (US$0.37–0.50) 23 Borrowing money is required for 33% of the respondents interviewed.
36–44 (US$0.51–0.63) 11 Borrowing money is required for 56% of the respondents interviewed.
45–60 (US$0.64–0.85) 33 Borrowing money is required for 67% of the respondents interviewed.
Total 100
*Conversion based on international exchange rates as of December 2010: US$1 = Bangladeshi Tk. 70.
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have influenced the participants in making their choice
of product and price options could be their experience
of using other products including price, knowledge and
practice of prevention and treatment of cord infection.
Most of the respondents were familiar with some symp-
toms of cord infection and types of indigenous and allo-
pathic preparation used for cord care. This familiarity
with the condition of interest and currently available
products has enhanced the understanding of the hypo-
thetical scenario related to valuation of 7.1% chlorhexi-
dine digluconate products.
Conclusions
A unit price of Tk. 15 to Tk. 25 (US$0.21 to US$0.35)
for multi-dose 7.1% chlorhexidine (delivering 4% chlor-
hexidine liquid would be affordable to the primary target
population in Bangladesh. Although large market demand
could be generated if the product were made available at
this price point, subsidization may be required to achieve
optimal coverage. A subsidization strategy would be espe-
cially important to reach poorer mothers since those
families that have home births often make out-of-pocket
payments to receive care. Increasing availability and acces-
sibility to chlorhexidine for umbilical cord care may pro-
vide an avenue for attaining MDG 4 through a reduction
in neonatal mortality.
Additional file
Additional file 1: Questionnaire for willingness to pay for 4%
chlorhexidine products in rural Bangladesh.
Abbreviations
Tk: Bangladeshi taka; CVM: Contingent valuation method; icddr,
b: International Centre for Diarrhoeal Disease Research, Bangladesh;
MDG: Millennium development goals; PATH: Program for Appropriate
Technology in Health; USAID: United States Agency for International
Development; WTP: Willingness to pay.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PC, MM, and TK developed the concept and design for the study; ZI acted as
Principal Investigator, and conducted field research and data analysis; all
authors drafted, read, and approved the final manuscript.Acknowledgements
Reported by: icddr,b and PATH.
Supported by: This study was made possible by the generous support of the
American people through the United States Agency for International
Development (USAID) under the HealthTech program, cooperative
agreement #GPH-A-00-01-0005-00. The contents are the responsibility of
PATH and icddr,b and do not necessarily reflect the views of USAID or the
United States Government.
Author details
1Technology Solutions Global Program, PATH, 2201 Westlake Ave, Seattle,
WA 98121, USA. 2Centre for Equity & Health Systems, icddr,b, Mohakhali,
Dhaka 1000, Bangladesh. 3Headquarters, United States Marine Corps, 3000
Marine Corps, Pentagon, Washington, DC 20350, USA.
Received: 11 April 2013 Accepted: 10 October 2013
Published: 18 October 2013References
1. United Nations: The Millennium Development Goals Report 2010. New York:
United Nations; 2010.
2. United Nations Commission on Life-Saving Commodities webpage. http://
www.everywomaneverychild.org/resources/un-commission-on-life-saving-
commodities/life-saving-commodities.
3. World Health Organization: Care of the Umbilical Cord. WHO/RHT/MSM/98.4.
Geneva: WHO; 1999.
4. Capurro H: Topical Umbilical Cord Care at Birth: RHL Commentary. http://
apps.who.int/rhl/newborn/cd001057_capurroh_com/en/index.html.
5. National Institute of Population Research and Training, MEASURE
Evaluation, UNC-CH, icddr,b: Bangladesh Maternal Mortality and Health Care
Survey 2010: Preliminary results; 2010. http://www.cpc.unc.edu/measure/
publications/tr-12-87.
6. Arifeen SE, Mullany LC, Shah R, Mannan I, Rahman SM, Talukder MR, Begum
N, Al-Kabir A, Darmstadt GL, Santosham M, Black RE, Baqui AH: The effect of
cord cleansing with chlorhexidine on neonatal mortality in rural
Bangladesh: a community-based, cluster-randomised trial. Lancet 2012,
379(9820):1022–1028.
7. Mullany LC, Darmstadt GL, Khatry SK, Katz J, LeClerq SC, Shrestha S, Adhikari
R, Tielsch JM: Topical applications of chlorhexidine to the umbilical for
prevention of omphalitis and neonatal mortality in southern Nepal: a
community‐based, cluster‐randomised trial. Lancet 2006, 367:910–918.
8. Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta ZA: Topical application of
chlorhexidine to neonatal umbilical cords for prevention of omphalitis and
neonatal mortality in a rural district of Pakistan: a community-based,
cluster-randomised trial. Lancet 2012, 379(9820):1029–1036.
9. Imdad A, Mullany LC, Baqui AH, Arifeen SE, Tielsch JM, Khatry SK, Shah R,
Cousens S, Black RE, Bhutta ZA: The effect of umbilical cord cleansing
with chlorhexidine on omphalitis and neonatal mortality in community
settings in developing countries: a meta-analysis. BMC Public Health 2013,
13(Suppl 3):S15.
10. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H,
Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference
Group of WHO and UNICEF: Global, regional, and national causes of child
mortality: an updated systematic analysis for 2010 with time trends
since 2000. Lancet 2012, 379(9832):2151–2161.
11. Whittington D: Improving performance of contingent valuation studies in
developing countries. Environ Resour Econ 2002, 22:323–367.
Coffey et al. BMC International Health and Human Rights 2013, 13:44 Page 9 of 9
http://www.biomedcentral.com/1472-698X/13/4412. Foreit KG, Foreit JR: Willingness to Pay Surveys for Setting Prices for Reproductive
Health Products and Services: A User’s Manual. New York: Population Council;
2004. www.popcouncil.org/pdfs/frontiers/Capacity_Bldg/WTP_Manual.pdf.
13. Rabbani A, Alexander GC: The association between family structure,
reports of illness and health care demand for children: evidence from
rural Bangladesh. J Biosoc Sci 2009, 41(5):645–659.
14. Hodgins S, Thapa K, Khanal L, Aryal S, Suvedi BK, Baidya U, Mullany LC:
Chlorhexidine gel versus aqueous for preventive use on umbilical
stump: a randomized noninferiority trial. Pediatr Infect Dis J 2010,
29(11):999–1003.
15. Bhatia MR, Fox-Rushby A: Validity of willingness to pay: hypothetical
versus actual payment. Appl Econ Lett 2003, 10:737–740.
16. McNamee P, Ternent L, Gbangou A, Newlands D: A game of two halves?
Incentive incompatibility, starting point bias and the bidding game
contingent valuation method. Health Econ 2010, 19(1):75–87.
doi:10.1186/1472-698X-13-44
Cite this article as: Coffey et al.: Willingness to pay for a 4%
chlorhexidine (7.1% chlorhexidine digluconate) product for umbilical
cord care in rural Bangladesh: a contingency valuation study. BMC
International Health and Human Rights 2013 13:44.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
